Jane Street
ONC

Jane Street’s BeOne Medicines Ltd ONC Stock Holding History

Jane Street’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.46M Buy
18,400
+10,700
+139% +$3.46M ﹤0.01% 3377
2025
Q4 		$2.34M Sell
7,700
-11,700
-60% -$3.83M ﹤0.01% 4499
2025
Q3 		$6.61M Buy
19,400
+1,400
+8% +$425K ﹤0.01% 2993
2025
Q2 		$4.36M Buy
18,000
+800
+5% +$196K ﹤0.01% 3189
2025
Q1 		$4.68M Buy
17,200
+1,300
+8% +$304K ﹤0.01% 3033
2024
Q4 		$2.94M Buy
15,900
+6,400
+67% +$1.31M ﹤0.01% 3488
2024
Q3 		$2.13M Buy
9,500
+7,300
+332% +$1.31M ﹤0.01% 4352
2024
Q2 		$314K Sell
2,200
-5,300
-71% -$817K ﹤0.01% 7730
2024
Q1 		$1.17M Sell
7,500
-800
-10% -$129K ﹤0.01% 5110
2023
Q4 		$1.5M Buy
8,300
+2,500
+43% +$452K ﹤0.01% 4824
2023
Q3 		$1.04M Buy
5,800
+2,000
+53% +$396K ﹤0.01% 5121
2023
Q2 		$678K Sell
3,800
-100
-3% -$23K ﹤0.01% 5843
2023
Q1 		$841K Sell
3,900
-13,300
-77% -$3.19M ﹤0.01% 5343
2022
Q4 		$3.78M Buy
+17,200
New +$3.15M ﹤0.01% 2867
2022
Q3 		– Sell
-1,900
Closed -$308K – 10639
2022
Q2 		$308K Sell
1,900
-6,200
-77% -$968K ﹤0.01% 7573
2022
Q1 		$1.53M Buy
8,100
+5,000
+161% +$1.06M ﹤0.01% 5263
2021
Q4 		$840K Sell
3,100
-6,200
-67% -$2.09M ﹤0.01% 6257
2021
Q3 		$3.38M Buy
+9,300
New +$3.04M ﹤0.01% 3436
2021
Q2 		– Sell
-12,500
Closed -$4.35M – 10545
2021
Q1 		$4.35M Sell
12,500
-3,200
-20% -$1.06M ﹤0.01% 2607
2020
Q4 		$4.06M Buy
15,700
+13,900
+772% +$3.83M ﹤0.01% 2394
2020
Q3 		$516K Buy
+1,800
New +$423K ﹤0.01% 5103
2020
Q1 		– Sell
-7,600
Closed -$1.26M – 6122
2019
Q4 		$1.26M Buy
+7,600
New +$1.26M ﹤0.01% 2478

Other funds holding ONC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Jane Street's ONC Position: Q1 2026 in Review

Jane Street opened a new position in BeOne Medicines Ltd (ONC) in Q1 2026: 75,953 shares worth $22.6M. The stake represents ﹤0.01% of the portfolio and ranks #1679 among its holdings. This is a return to the name: Jane Street previously reported a position in ONC as recently as Q3 2025.

Jane Street first reported a position in ONC in Q3 2017 and has held it in 25 quarters since. The position peaked at $24.4M in Q1 2025. 282 funds tracked by Wall St. Rank hold ONC as of Q1 2026.

  • Jane Street held 75,953 shares of BeOne Medicines Ltd worth $22.6M as of Q1 2026.
  • BeOne Medicines Ltd was a new Jane Street position in Q1 2026.
  • BeOne Medicines Ltd made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #1679 holding.
  • Jane Street first reported a position in BeOne Medicines Ltd in Q3 2017 and has held it in 25 quarters since.
  • Jane Street's BeOne Medicines Ltd position peaked at $24.4M in Q1 2025.
  • 282 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.